These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3925393)

  • 1. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.
    Baumeister AA; Frye GD
    Neurosci Biobehav Rev; 1985; 9(2):169-78. PubMed ID: 3925393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical basis of the neurobehavioral abnormalities in the Lesch-Nyhan syndrome: a hypothesis.
    Neychev VK; Mitev VI
    Med Hypotheses; 2004; 63(1):131-4. PubMed ID: 15193365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
    Lloyd KG; Hornykiewicz O; Davidson L; Shannak K; Farley I; Goldstein M; Shibuya M; Kelley WN; Fox IH
    N Engl J Med; 1981 Nov; 305(19):1106-11. PubMed ID: 6117011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neurotransmission in Lesch-Nyhan syndrome.
    Deutsch SI; Long KD; Rosse RB; Mastropaolo J; Eller J
    Clin Neuropharmacol; 2005; 28(1):28-37. PubMed ID: 15711436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine function in Lesch-Nyhan disease.
    Nyhan WL
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):409-11. PubMed ID: 10852837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.
    Dammer EB; Göttle M; Duong DM; Hanfelt J; Seyfried NT; Jinnah HA
    Mol Genet Metab; 2015 Apr; 114(4):570-579. PubMed ID: 25769394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects of tetrahydrobiopterin synthesis and their possible relationship to a disorder of purine metabolism (the Lesch-Nyhan syndrome).
    Watts RW
    Adv Enzyme Regul; 1985; 23():25-58. PubMed ID: 2866676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families.
    Puig JG; Torres RJ; Mateos FA; Ramos TH; Arcas JM; Buño AS; O'Neill P
    Medicine (Baltimore); 2001 Mar; 80(2):102-12. PubMed ID: 11307586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gilles de la Tourette syndrome: further studies and thoughts.
    Singer HS; Pepple JM; Ramage AL; Butler IJ
    Ann Neurol; 1978 Jul; 4(1):21-5. PubMed ID: 279303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic and psychiatric aspects of Lesch-Nyhan syndrome].
    Heidelmann G; Knauthe M
    Psychiatr Neurol Med Psychol (Leipz); 1982 Feb; 34(2):79-87. PubMed ID: 7089122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome.
    Bakay B; Nissinen E; Sweetman L; Francke U; Nyhan WL
    Pediatr Res; 1979 Dec; 13(12):1365-70. PubMed ID: 523196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Lesch-Nyhan disease with S-adenosylmethionine: experience with five young Malaysians, including a girl.
    Chen BC; Balasubramaniam S; McGown IN; O'Neill JP; Chng GS; Keng WT; Ngu LH; Duley JA
    Brain Dev; 2014 Aug; 36(7):593-600. PubMed ID: 24055166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan syndrome.
    Stacey NC; Ma MH; Duley JA; Connolly GP
    Neuroscience; 2000; 98(2):397-401. PubMed ID: 10854773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: possible pharmacological model for Lesch-Nyhan syndrome.
    Goldstein M; Kuga S; Kusano N; Meller E; Dancis J; Schwarcz R
    Brain Res; 1986 Mar; 367(1-2):114-20. PubMed ID: 2938664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
    García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
    Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease.
    Jinnah HA; Jones MD; Wojcik BE; Rothstein JD; Hess EJ; Friedmann T; Breese GR
    J Neurochem; 1999 Jan; 72(1):225-9. PubMed ID: 9886073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.